URGN
NASDAQ HealthcareUroGen Pharma Ltd. - Ordinary Shares
Biotechnology
📊 Market Data
| Price | $18.79 |
|---|---|
| Volume | 625,341 |
| Market Cap | 914.74M |
| Beta | 1.370 |
| RSI (14-Day) | 36.9 |
| 200-Day MA | $18.77 |
| 50-Day MA | $20.72 |
| 52-Week High | $30.00 |
| 52-Week Low | $3.42 |
| Forward P/E | 20.37 |
| Price / Book | -8.62 |
🎯 Investment Strategy Scores
How URGN scores across each investment strategy. Higher is better for that strategy's goals.
💰 Dividend Daddy
16/100
High dividend yield + low volatility
🚀 Moon Shot
73/100
High growth potential (high beta + oversold)
🔪 Falling Knife
48/100
Contrarian plays (oversold + below moving average)
🎈 Over-Hyped
47/100
Overbought stocks (potential short candidates)
🐋 Institutional Whale
24/100
Large-cap, institutional-quality stocks
Find URGN in your text
Paste any text on the homepage — the tool will extract URGN and other hidden tickers.
Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.